Table of Contents Author Guidelines Submit a Manuscript
International Journal of Breast Cancer
Volume 2012, Article ID 516417, 7 pages
http://dx.doi.org/10.1155/2012/516417
Review Article

Current Operative Management of Breast Cancer: An Age of Smaller Resections and Bigger Cures

Department of Surgery, Mitchell Cancer Institute, University of South Alabama, 1660 Springhill Avenue Mobile, AL 36604, USA

Received 13 August 2011; Revised 5 November 2011; Accepted 9 November 2011

Academic Editor: Rajeev S. Samant

Copyright © 2012 Jack W. Rostas and Donna Lynn Dyess. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. American Cancer Society, Cancer Facts & Figures, American Cancer Society, Atlanta, Ga, USA, 2011.
  2. N Howlader, A Noone, M. Krapcho et al., “SEER Cancer Statistics Review, 1975–2008,” National Cancer Institute. Bethesda, Md, USA, November 2010, http://seer.cancer.gov/csr/1975_2008/.
  3. American Cancer Society, Breast Cancer Facts & Figures 2011-2012, American Cancer Society, Atlanta, Ga, USA, 2012.
  4. G. H. Sakorafas and M. Safioleas, “Breast cancer surgery: an historical narrative. Part I. from prehistoric times to Renaissance,” European Journal of Cancer Care, vol. 18, no. 6, pp. 530–544, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. G. H. Sakorafas and M. Safioleas, “Breast cancer surgery: an historical narrative. Part III. From the sunset of the 19th to the dawn of the 21st century,” European Journal of Cancer Care, vol. 19, no. 2, pp. 145–166, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. M. G. Berry, A. D. Fitoussi, A. Curnier, B. Couturaud, and R. J. Salmon, “Oncoplastic breast surgery: a review and systematic approach,” Journal of Plastic, Reconstructive and Aesthetic Surgery, vol. 63, no. 8, pp. 1233–1243, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. R. W. Carlson, D. C. Allred, B. O. Anderson et al., “Invasive breast cancer: clinical practice guidelines in oncology,” JNCCN Journal of the National Comprehensive Cancer Network, vol. 9, no. 2, pp. 136–222, 2011. View at Google Scholar
  8. M. Morrogh, “Breast-conserving surgery,” in Kuerer’s Breast Surgical Oncology, H. M. Kuerer, Ed., chapter 61, McGraw-Hill, 2010. View at Google Scholar
  9. HB Neuman and K. J. Van Zee, “Axillary lymph node dissection,” in Kuerer’s Breast Surgical Oncology, H. M. Kuerer, Ed., chapter 63, McGraw-Hill, 2010. View at Google Scholar
  10. B. A. Virnig, T. M. Tuttle, T. Shamliyan, and R. L. Kane, “Ductal carcinoma in Situ of the breast: a systematic review of incidence, treatment, and outcomes,” Journal of the National Cancer Institute, vol. 102, no. 3, pp. 170–178, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. R. W. Carlson, D. C. Allred, B. O. Anderson et al., “Breast cancer: Noninvasive and special situations,” Journal of the National Comprehensive Cancer Network, vol. 8, no. 10, pp. 1182–1207, 2010. View at Google Scholar
  12. I. Makhoul and E. Kiwan, “Neoadjuvant systemic treatment of breast cancer,” Journal of Surgical Oncology, vol. 103, no. 4, pp. 348–357, 2011. View at Publisher · View at Google Scholar · View at PubMed
  13. M. C. Green, A. U. Buzdar, T. Smith et al., “Weekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every 3 weeks,” Journal of Clinical Oncology, vol. 23, no. 25, pp. 5983–5992, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. E. Montagna, V. Bagnardi, N. Rotmensz et al., “Pathological complete response after preoperative systemic therapy and outcome: relevance of clinical and biologic baseline features,” Breast Cancer Research and Treatment, vol. 124, no. 3, pp. 689–699, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. M. Tanioka, C. Shimizu, K. Yonemori et al., “Predictors of recurrence in breast cancer patients with a pathologic complete response after neoadjuvant chemotherapy,” British Journal of Cancer, vol. 103, no. 3, pp. 297–302, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. A. D. Baildam, “Oncoplastic surgery for breast cancer,” British Journal of Surgery, vol. 95, no. 1, pp. 4–5, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. A. E. Giuliano, K. K. Hunt, K. V. Ballman et al., “Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial,” Journal of the American Medical Association, vol. 305, no. 6, pp. 569–575, 2011. View at Publisher · View at Google Scholar · View at PubMed
  18. J. C. Boughey, T. L. Hoskin, A. C. Degnim et al., “Contralateral prophylactic mastectomy is associated with a survival advantage in high-risk women with a personal history of breast cancer,” Annals of Surgical Oncology, vol. 17, no. 10, pp. 2702–2709, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. B. A. Pockaj, N. Wasif, A. C. Dueck et al., “Metastasectomy and surgical resection of the primary tumor in patients with stage IV breast cancer: time for a second look?” Annals of Surgical Oncology, vol. 17, no. 9, pp. 2419–2426, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. O. Pagani, E. Senkus, W. Wood et al., “International guidelines for management of metastatic breast cancer: can metastatic breast cancer be cured?” Journal of the National Cancer Institute, vol. 102, no. 7, pp. 456–463, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. H. Kennecke, R. Yerushalmi, R. Woods et al., “Metastatic behavior of breast cancer subtypes,” Journal of Clinical Oncology, vol. 28, no. 20, pp. 3271–3277, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. G. H. De Bock, H. Putter, J. Bonnema, J. A. Van Der Hage, H. Bartelink, and C. J. Van De Velde, “The impact of loco-regional recurrences on metastatic progression in early-stage breast cancer: a multistate model,” Breast Cancer Research and Treatment, vol. 117, no. 2, pp. 401–408, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. E. Botteri, V. Bagnardi, N. Rotmensz et al., “Analysis of local regional recurrences in breast cancer after conservative surgery,” Annals of Oncology, vol. 21, no. 4, pp. 723–728, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. M. R. Kell, C. Dunne, J. P. Burke, and M. Morrow, “Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ,” Journal of Clinical Oncology, vol. 27, no. 10, pp. 1615–1620, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. S. T. Ward, B. G. Jones, and A. J. Jewkes, “A two-millimetre free margin from invasive tumour minimises residual disease in breast-conserving surgery,” International Journal of Clinical Practice, vol. 64, no. 12, pp. 1675–1680, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. S. J. Anderson, I. Wapnir, J. J. Dignam et al., “Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five national surgical adjuvant breast and bowel project protocols of node-negative breast cancer,” Journal of Clinical Oncology, vol. 27, no. 15, pp. 2466–2473, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. B. Biggers, S. Knox, M. Grant et al., “Circulating tumor cells in patients undergoing surgery for primary breast cancer: preliminary results of a pilot study,” Annals of Surgical Oncology, vol. 16, no. 4, pp. 969–971, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. X.-C. Hu, W. T. Y. Loo, and L. W. C. Chow, “Surgery-related shedding of breast cancer cells as determined by RT-PCR assay,” Journal of Surgical Oncology, vol. 82, no. 4, pp. 228–232, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. X. Y. An, H. Egami, N. Hayashi, Y. Kurusu, J. I. Yamashita, and M. Ogawa, “Clinical significance of circulating cancer cells in peripheral blood detected by reverse transcriptase-polymerase chain reaction in patients with breast cancer,” Tohoku Journal of Experimental Medicine, vol. 193, no. 2, pp. 153–162, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. I. J. Bleiweiss, C. S. Nagi, and S. Jaffer, “Axillary sentinel lymph nodes can be falsely positive due to iatrogenic displacement and transport of benign epithelial cells in patients with breast carcinoma,” Journal of Clinical Oncology, vol. 24, no. 13, pp. 2013–2018, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. N. M. Hansen, X. Ye, B. J. Grube et al., “Manipulation of the primary breast tumor and the incidence of sentinel node metastases from invasive breast cancer,” Archives of Surgery, vol. 139, no. 6, pp. 634–640, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. B. A. Carter, R. A. Jensen, J. F. Simpson, and D. L. Page, “Benign transport of breast epithelium into axillary lymph nodes after biopsy,” American Journal of Clinical Pathology, vol. 113, no. 2, pp. 259–265, 2000. View at Google Scholar · View at Scopus
  33. M. Cristofanilli, G. T. Budd, M. J. Ellis et al., “Circulating tumor cells, disease progression, and survival in metastatic breast cancer,” New England Journal of Medicine, vol. 351, no. 8, pp. 781–791, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. M. C. Miller, G. V. Doyle, and L. W. Terstappen, “Significance of circulating tumor cells detected by the CellSearch system in patients with metastatic breast colorectal and prostate cancer,” Journal of Oncology, vol. 2010, Article ID 617421, 8 pages, 2010. View at Publisher · View at Google Scholar · View at PubMed
  35. O. Camara, A. Kavallaris, H. Nöschel, M. Rengsberger, C. Jörke, and K. Pachmann, “Seeding of epithelial cells into circulation during surgery for breast cancer: the fate of malignant and benign mobilized cells,” World Journal of Surgical Oncology, vol. 4, article no. 67, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. N. Sawabata, M. Okumura, T. Utsumi et al., “Circulating tumor cells in peripheral blood caused by surgical manipulation of non-small-cell lung cancer: pilot study using an immunocytology method,” General Thoracic and Cardiovascular Surgery, vol. 55, no. 5, pp. 189–192, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. M. Yilmaz, G. Christofori, and F. Lehembre, “Distinct mechanisms of tumor invasion and metastasis,” Trends in Molecular Medicine, vol. 13, no. 12, pp. 535–541, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. M. Mareel, M. J. Oliveira, and I. Madani, “Cancer invasion and metastasis: interacting ecosystems,” Virchows Archiv, vol. 454, no. 6, pp. 599–622, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. W. W. Harless, “Cancer treatments transform cancer cell phenotype,” Cancer Cell International, vol. 11, article 1, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. M. T. Sandri, L. Zorzino, M. C. Cassatella et al., “Changes in circulating tumor cell detection in patients with localized breast cancer before and after surgery,” Annals of Surgical Oncology, vol. 17, no. 6, pp. 1539–1545, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus